Fisetin induces G2/M phase cell cycle arrest by inactivating cdc25C-cdc2 via ATM-Chk1/2 activation in human endometrial cancer cells

Authors

  • Zhan-Ying Wang Department of Obstetrics and Gynecology, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, China
  • Wen-Qiong Liu Department of Obstetrics and Gynecology, The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China
  • Si'e Wang Department of Obstetrics and Gynecology, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, China
  • Zeng-Tao Wei Department of Obstetrics and Gynecology, Jinan Central Hospital Affiliated to Shandong University, No. 105, Jiefang Road, Lixia District, Jinan, Shandong 250013, China

DOI:

https://doi.org/10.3329/bjp.v10i2.21945

Keywords:

ATM, Chk1/2, Cdc25C, endometrial cancer, fisetin, G2/M cell cycle phase

Abstract

Endometrial cancer is one of the most prevalent gynaecological malignancies where, currently available therapeutic options remain limited. Recently phytochemicals are exploited for their efficiency in cancer therapy. The present study investigates the anti-proliferative effect of fisetin, a flavonoid on human endometrial cancer cells (KLE and Hec1 A). Fisetin (20-100 µM) effectively reduced the viability of Hec1 A and KLE cells and potentially altered the cell population at G2/M stage. Expression levels of the cell cycle proteins (cyclin B1, p-Cdc2, p-Cdc25C, p-Chk1, Chk2, p-ATM, cyclin B1, H2AX, p21 and p27) were analyzed. Fisetin suppressed cyclin B1 expression and caused inactiva-tion of Cdc25C and Cdc2 by increasing their phosphorylation levels and further activated ATM, Chk1 and Chk2. Increased levels of p21 and p27 were observed as well. These results suggest that fisetin induced G2/M cell cycle arrest via inactivating Cdc25c and Cdc2 through activation of ATM, Chk1 and Chk2.

Downloads

Download data is not yet available.
Abstract
684
Download
326 Read
140

Downloads

Additional Files

Published

2015-04-03

How to Cite

Wang, Z.-Y., W.-Q. Liu, S. Wang, and Z.-T. Wei. “Fisetin Induces G2/M Phase Cell Cycle Arrest by Inactivating cdc25C-Cdc2 via ATM-Chk1/2 Activation in Human Endometrial Cancer Cells”. Bangladesh Journal of Pharmacology, vol. 10, no. 2, Apr. 2015, pp. 279-87, doi:10.3329/bjp.v10i2.21945.

Issue

Vol. 10 No. 2 (2015)

Section

Research Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).